Vitamin E in nature is comprised of a family of
tocopherols and
tocotrienols. The most studied of these is
alpha-tocopherol (alpha-TOH), because this form is retained within the body, and
vitamin E deficiency is corrected with this supplement. alpha-TOH is a
lipid-soluble
antioxidant required for the preservation of cell membranes, and it potentially acts as a defense against oxidative stress. Many studies have investigated the metabolism, transport, and efficacy alpha-TOH in the prevention of sequelae associated with
cardiovascular disease (CVD). Supplementation with
vitamin E is considered to provide health benefits against CVD through its
antioxidant activity, the prevention of
lipoprotein oxidation, and the inhibition of platelet aggregation. However, the results from large prospective, randomized, placebo-controlled clinical trials with alpha-TOH have been largely negative. A recent meta-analysis suggests that alpha-TOH supplements may actually increase all-cause mortality; however, the mechanism for this increased risk is unknown. In vitro studies performed in human cell cultures and animal models suggest that
vitamin E might increase the hepatic production of
cytochrome P450s and MDR1. Induction of
CYP3A4 or MDR1 by
vitamin E could potentially lower the efficacy of any
drug metabolized by
CYP3A4 or MDR1. Other possibilities include an adverse effect of alpha-TOH on blood pressure in high-risk populations. Because of the wide popularity and use of
vitamin E supplements, further research into potential adverse effects is clearly warranted.